Monday, August 29, 2016 5:56:39 PM
Sept21-22 2016: “Phacilitate’s Immunotherapy Europe (Strategic Partnering Event)” Berlin, GER
“The Perfect Combination of Strategy & Innovation - Advancing immuno-oncology business & R&D models at Europe’s inaugural strategic partnering event. Delivering combination therapy, biomarkers, imaging, pricing & reimbursement, R&D and supply chain models to ensure next-generation immuno-oncology success.”
http://www.cgteurope.com/page.cfm/action=Seminar/libID=1/libEntryID=47
**PHACILITATE is a specialist in the organization of exclusive events for leaders from the pharma & biotech communities. Our philosophy is simple - to deliver the ultimate in strategic knowledge exchange & networking through flawless, personalized service.
9-22-16 9:50-10:20am WEBINAR:
“Analyzing The Business & Partnering Model In Industry & Academia For The Future Development Of Immuno-Oncology Combination Therapies”
Panelists/Speakers:
* Donnie McGrath - VP, Head Search & Evaluation, BusDev, Bristol-Myers Squibb
* Emmett Schmidt = Exec.Dir., Clinical Research, Merck Sharp & Dohme
* Jennifer Buell VP, Development Operations, Agenus
* Steven King – Pres. & CEO, Peregrine Pharmaceuticals - http://www.cgteurope.com/page.cfm/Action=Visitor/VisitorID=139
.
Recent CDMO News
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM
